Umbilical cord blood-derived mononuclear cells (Mayo Clinic)

N/A

Report date: 2026/04/28 20:00:22

Base Information

Drug NameUmbilical cord blood-derived mononuclear cells (Mayo Clinic)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Source of cells > Umbilical cord blood-derivedCell and gene therapy > Cell therapy > Immune system cell therapy > Leukocyte cell therapy > Monocyte cell therapyCell and gene therapy > Cell therapy > Donor > Autologous
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsHypoplastic Left Heart Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMayo Clinic
China Registration ClassN/A

Develop Information

Active CompaniesThe University Of Oklahoma
Inactive CompaniesMayo Clinic
Active IndicationsHypoplastic Left Heart Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A